In case of T-LGLL, no association with other clinical features was found (different from those associated to STAT3 mutations in TαβCD8+ LGLL), and in all cases with follow-up data (n=17), the disease remained stable without therapy. Here, STAT3 is linked to T-cell large granular lymphocyte leukemia.